FFCP PHASE1:Mm9::chr18:75439125..75439129,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=280|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr18:75439125..75439129,+|id=chr18:75439125..75439129,+|ontology_enrichment_celltype=CL:0000838!5.30e-36!12;CL:0000542!3.64e-33!13;CL:0000051!3.64e-33!13;CL:0000084!5.04e-31!11;CL:0000827!5.04e-31!11;CL:0000988!2.58e-27!32;CL:0002032!2.58e-27!32;CL:0000037!2.58e-27!32;CL:0000566!2.58e-27!32;CL:0000837!2.58e-27!32;CL:0000738!3.81e-25!17;CL:0002087!3.81e-25!17;CL:0000791!7.67e-22!9;CL:0000789!7.67e-22!9;CL:0002420!7.67e-22!9;CL:0002419!7.67e-22!9;CL:0000790!7.67e-22!9;CL:0002031!1.09e-20!25;CL:0002320!1.61e-18!46;CL:0000134!1.61e-18!46;CL:0000624!4.94e-17!8;CL:0000219!1.56e-15!54;CL:0000034!7.49e-13!97;CL:0000063!2.12e-12!66;CL:0000144!6.46e-10!121;CL:0000012!6.46e-10!121;CL:0000893!1.65e-08!6;CL:0002489!1.65e-08!6;CL:0000898!1.65e-08!6;CL:0000809!1.65e-08!6;CL:0000810!1.65e-08!6;CL:0000895!1.65e-08!6;CL:0000808!1.65e-08!6;CL:0000894!1.65e-08!6;CL:0000806!1.65e-08!6;CL:0000807!1.65e-08!6;CL:0000805!1.65e-08!6;CL:0002425!1.65e-08!6;CL:0002436!1.65e-08!6;CL:0002427!1.65e-08!6;CL:0002428!1.65e-08!6;CL:0002429!1.65e-08!6;CL:0002433!1.65e-08!6;CL:0002431!1.65e-08!6;CL:0002432!1.65e-08!6;CL:0000723!1.65e-08!91;CL:0000048!1.65e-08!91;CL:0000625!2.75e-07!1;CL:0000815!5.34e-07!1;CL:0000792!5.34e-07!1;CL:0000945!6.09e-07!1;CL:0000236!6.09e-07!1;CL:0000826!6.09e-07!1|ontology_enrichment_celltype_v019_2=CL:0000838,4.88e-17,12;CL:0000542,9.01e-16,13;CL:0000051,9.01e-16,13;CL:0000625,3.62e-14,1;CL:0000815,1.55e-13,1;CL:0000792,1.55e-13,1;CL:0000945,2.06e-13,1;CL:0000236,2.06e-13,1;CL:0000826,2.06e-13,1;CL:0000791,3.07e-13,9;CL:0000789,3.07e-13,9;CL:0002420,3.07e-13,9;CL:0002419,3.07e-13,9;CL:0000790,3.07e-13,9;CL:0000738,3.47e-12,17;CL:0002087,3.47e-12,17;CL:0000084,5.80e-11,11;CL:0000827,5.80e-11,11;CL:0002031,1.96e-08,25;CL:0000624,3.77e-07,8|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0002384!1.61e-18!46|ontology_enrichment_uberon_v019_2=|phase1_expression=0,0,0,0,0,0,0,1.16210991097419,0.140788722151667,0,0,0,0.342401459862411,0.174840804837995,0,0.202475267389826,0,0,0,0,0,0.0992909512008853,0.522399578277871,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.00669563634642,1.45072428402269,2.01656279485478,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.838705871541442,0.599902730993408,0.508280908292259,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.18984900995699,1.81936888020755,1.52019971184866,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p@chr18:75439125..75439129,+}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=280 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr18:75439125..75439129,+ | |||
|description=CAGE_peak_at_chr18:75439125..75439129,+ | |||
|id=chr18:75439125..75439129,+ | |||
|ontology_enrichment_celltype=CL:0000838!5.30e-36!12;CL:0000542!3.64e-33!13;CL:0000051!3.64e-33!13;CL:0000084!5.04e-31!11;CL:0000827!5.04e-31!11;CL:0000988!2.58e-27!32;CL:0002032!2.58e-27!32;CL:0000037!2.58e-27!32;CL:0000566!2.58e-27!32;CL:0000837!2.58e-27!32;CL:0000738!3.81e-25!17;CL:0002087!3.81e-25!17;CL:0000791!7.67e-22!9;CL:0000789!7.67e-22!9;CL:0002420!7.67e-22!9;CL:0002419!7.67e-22!9;CL:0000790!7.67e-22!9;CL:0002031!1.09e-20!25;CL:0002320!1.61e-18!46;CL:0000134!1.61e-18!46;CL:0000624!4.94e-17!8;CL:0000219!1.56e-15!54;CL:0000034!7.49e-13!97;CL:0000063!2.12e-12!66;CL:0000144!6.46e-10!121;CL:0000012!6.46e-10!121;CL:0000893!1.65e-08!6;CL:0002489!1.65e-08!6;CL:0000898!1.65e-08!6;CL:0000809!1.65e-08!6;CL:0000810!1.65e-08!6;CL:0000895!1.65e-08!6;CL:0000808!1.65e-08!6;CL:0000894!1.65e-08!6;CL:0000806!1.65e-08!6;CL:0000807!1.65e-08!6;CL:0000805!1.65e-08!6;CL:0002425!1.65e-08!6;CL:0002436!1.65e-08!6;CL:0002427!1.65e-08!6;CL:0002428!1.65e-08!6;CL:0002429!1.65e-08!6;CL:0002433!1.65e-08!6;CL:0002431!1.65e-08!6;CL:0002432!1.65e-08!6;CL:0000723!1.65e-08!91;CL:0000048!1.65e-08!91;CL:0000625!2.75e-07!1;CL:0000815!5.34e-07!1;CL:0000792!5.34e-07!1;CL:0000945!6.09e-07!1;CL:0000236!6.09e-07!1;CL:0000826!6.09e-07!1 | |||
|ontology_enrichment_celltype_v019_2=CL:0000838,4.88e-17,12;CL:0000542,9.01e-16,13;CL:0000051,9.01e-16,13;CL:0000625,3.62e-14,1;CL:0000815,1.55e-13,1;CL:0000792,1.55e-13,1;CL:0000945,2.06e-13,1;CL:0000236,2.06e-13,1;CL:0000826,2.06e-13,1;CL:0000791,3.07e-13,9;CL:0000789,3.07e-13,9;CL:0002420,3.07e-13,9;CL:0002419,3.07e-13,9;CL:0000790,3.07e-13,9;CL:0000738,3.47e-12,17;CL:0002087,3.47e-12,17;CL:0000084,5.80e-11,11;CL:0000827,5.80e-11,11;CL:0002031,1.96e-08,25;CL:0000624,3.77e-07,8 | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0002384!1.61e-18!46 | |||
|ontology_enrichment_uberon_v019_2= | |||
|phase1_expression=0,0,0,0,0,0,0,1.16210991097419,0.140788722151667,0,0,0,0.342401459862411,0.174840804837995,0,0.202475267389826,0,0,0,0,0,0.0992909512008853,0.522399578277871,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.00669563634642,1.45072428402269,2.01656279485478,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.838705871541442,0.599902730993408,0.508280908292259,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.18984900995699,1.81936888020755,1.52019971184866,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr18:75439125..75439129,+ | |||
}} |
Latest revision as of 03:15, 6 August 2015
Short description: | p@chr18:75439125..75439129, + |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr18:75439125..75439129, + |
Coexpression cluster: | MCL_coexpression_mm9:280 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
lymphoid lineage restricted progenitor cell | 4.88e-17 | 12 |
lymphocyte | 9.01e-16 | 13 |
common lymphoid progenitor | 9.01e-16 | 13 |
CD8-positive, alpha-beta T cell | 3.62e-14 | 1 |
regulatory T cell | 1.55e-13 | 1 |
CD4-positive, CD25-positive, alpha-beta regulatory T cell | 1.55e-13 | 1 |
lymphocyte of B lineage | 2.06e-13 | 1 |
B cell | 2.06e-13 | 1 |
pro-B cell | 2.06e-13 | 1 |
mature alpha-beta T cell | 3.07e-13 | 9 |
alpha-beta T cell | 3.07e-13 | 9 |
immature T cell | 3.07e-13 | 9 |
mature T cell | 3.07e-13 | 9 |
immature alpha-beta T cell | 3.07e-13 | 9 |
leukocyte | 3.47e-12 | 17 |
nongranular leukocyte | 3.47e-12 | 17 |
T cell | 5.80e-11 | 11 |
pro-T cell | 5.80e-11 | 11 |
hematopoietic lineage restricted progenitor cell | 1.96e-08 | 25 |
CD4-positive, alpha-beta T cell | 3.77e-07 | 8 |